SCSwetal Chouhan

Swetal Chouhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Swetal Chouhan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Glucocorticoid-Induced Osteoporosis Treatment by Prevailing Guidelines in a Tertiary Care Hospital

    by Abhijeet Kumar Agrawal, Prasan Deep Rath, Swetal Chouhan, Rahul Bisaralli, Hiren Kalyani, Jahnabi Bhagawati

    Background: Glucocorticoids are the primary drugs used in various disorders across the world. Longterm use of glucocorticoids opens a new Pandora’s box filled with several side effects, especially glucocorticoid-induced osteoporosis (GIOP). Patients with GIOP are seldom given treatment as per guidelines. Methods: This was a prospective observational study that included patients on glucocorticoids (dose equivalent to ≥ 2.5 mg prednisolone daily for at least 3 months). Fracture Risk Assessment (FRAX) tool scores were calculated for patients above the age of 40 years, and patients were segregated into low-, medium-, and high-risk categories of hip fractures and major osteoporotic fractures (MOPs). Results: This study included 116 patients, 85 (73.3%) of whom were females. The average dose of prednisolone was 8.39 mg/day. Only 15.5% of patients on glucocorticoids were ever evaluated for glucocorticoid-induced osteoporosis. This study showed that 44.8% and 23.3% of patients had a moderate to high risk of hip fracture and MOP, respectively. Only 7.8% of patients received bisphos phonate treatment. Conclusion: Glucocorticoid-induced osteoporosis is a prevalent yet neglected malady that acts as a slow knife, adding to the morbidity and mortality risk of an individual. The unchecked use of glucocorticoids in current clinical practice warrants greater concern from clinicians. This study serves as another reminder of the abyss of osteoporosis due to steroid use and how prevalent it is despite the vast amount of existing literature. Cite this article as: Agrawal KA, Rath PD, Chouhan S, Bisaralli R, Kalyani H, Bhagawati J. Assessment of glucocorticoid-induced osteoporosis treatment by prevailing guidelines in a tertiary care hospital. Eur J Rheumatol. 2025, 12(3), 0046, doi: 10.5152/eurjrheum.2025.24046.


  • Awareness, perspectives and satisfaction levels among patients with psoriatic arthritis: a multicentric cross-sectional survey

    by Himanshu Pathak, Mohit Goyal, Parthajit Das, Sham Santhanam, Ajaz Kariem Khan, Sourabh Malaviya, Akshat Pandey, Pravin Patil, Bimlesh Dhar Pandey, Prasandeep Rath, et al.

    Perception of the disease and its management impacts patients with Psoriatic arthritis (PsA) to a great degree. Studies examining patients’ viewpoints and perception of their disease and its management are scarce. This multicentric cross-sectional survey was undertaken to understand the perspectives of patients with PsA. A survey questionnaire with items on demographics, awareness about their disease, treatment, physical therapy, quality of life and satisfaction with the care received was designed. After internal and external validation, a pilot survey was conducted, and the questionnaire was finalized. The final survey (with translations in local languages) was carried out at 17 centres across India. There were 262 respondents (56% males) with mean age of 45.14 ± 12.89 years. In 40%, the time lag between onset of symptoms and medical assessment for it was more than a year. In most of the patients, the diagnosis of PsA was made by a rheumatologist. Over 83% of patients were consulting their rheumatologist periodically as advised and fully compliant with the treatment. Lack of time and cost of therapy were the most common reasons for non-adherence to therapy. Eighty-eight patients (34%) were not fully satisfied with their current treatment. Over two-third of patients had never seen a physiotherapist due to barriers including a lack of time, pain, and fatigue. The daily activities and employment status were affected in nearly 50% of patients with PsA. The current survey has identified a gap in patients’ awareness levels and helps healthcare providers in understanding the varied perceptions of patients with PsA. Addressing these issues in a systematic manner would potentially improve the treatment approaches, outcomes, and patient satisfaction levels.